T. Rowe Price Associates »

Leap Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $495k 119k 4.15
2023-09-30 $613k 444k 1.38
2023-06-30 $2.7M 857k 3.13

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Leap Therapeutics

Baker Bros. Advisors
Citadel Advisors
Samsara BioCapital
683 Capital Management
Vanguard Group
Key Client Fiduciary Advisors
T. Rowe Price Associates
Alyeska Investment Group
Perceptive Advisors
Susquehanna International
Hrt Financial
Advisor Group Holdings
Baystate Wealth Management
Simplex Trading
CNB Bank

View all funds holding Leap Therapeutics